AMCP CEO Blog: This truism lies at the heart of much of what managed care pharmacy does. AMCP members and their organizations have long championed the use of preventive-care services to achieve better health outcomes and lower overall health care costs.
AMCP was pleased that the bill, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974), bipartisan legislation designed to increase patient access to safe and affordable generic and biosimilar medicines and marketplace competition, continued to garner bipartisan support when it was voted out of the Judiciary Committee.
Partnership Forum: New health care innovations are bringing the promise of life changing treatment for specific diseases. It is imperative that financial models for innovative, high-investment medications be developed to maintain patient access. AMCP brought together thought leaders in July 2018 to discuss the issues and solutions needed on this key issue.